Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07473661 · ClinicalTrials.gov registry record · NA
Assessment of Skin Irritation and Sensitization of SILURCLOUD Fibrous Collagen Matrix
A NA study of Healthy Adult, sponsored by SerenaGroup.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT07473661 is a NA study of Healthy Adult that is actively recruiting participants, run by SerenaGroup. The registered enrollment target is 20 participants, below the 72-participant average among 8 other Healthy Adult trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07473661, a NA study of Healthy Adult, is actively recruiting participants, sponsored by SerenaGroup.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to evaluate the skin irritation and sensitization potential of SILURCLOUD™ Fibrous Collagen Matrix in healthy adult volunteers with Fitzpatrick Skin Types I and VI. The study will also generate additional safety data to address FDA 510(k) feedback regarding representation of these skin types. The main questions it aims to answer are: Does SILURCLOUD™ Fibrous Collagen Matrix cause primary or cumulative skin irritation under maximized patch test conditions? Does SILURCLOUD™ Fibrous Collagen Matrix demonstrate allergic contact sensitization potential in human subjects? Participants will: Have patches containing the test product applied to the skin under occlusive conditions Return for repeated patch applications during the induction phase Undergo skin evaluations using standardized scoring methods Complete a challenge phase following a rest period Participate in re-challenge testing if clinically indicated
Conditions Studied
Interventions
- DEVICE SILURCLOUD Fibrous Collagen Matrix
- DRUG 0.5% Sodium Lauryl Sulfate in Distilled Water
- DRUG Glycerosaline
Study Locations (1)
Pennsylvania
- SerenaGroup Monroeville - Monroeville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-02-27 |
| Est. Completion | 2026-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07473661
The ClinicalTrials.gov registry entry for NCT07473661 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 72-participant average among 8 other Healthy Adult trials with a reported enrollment target (72% lower). The listed sponsor is SerenaGroup, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Healthy Adult appearing as the primary indexed condition, and to 3 interventions - of which SILURCLOUD Fibrous Collagen Matrix is the first listed.
NCT07473661 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT07473661 about?
NCT07473661 is a clinical study titled "Assessment of Skin Irritation and Sensitization of SILURCLOUD Fibrous Collagen Matrix". The goal of this clinical trial is to evaluate the skin irritation and sensitization potential of SILURCLOUD™ Fibrous Collagen Matrix in healthy adult volunteers with Fitzpatrick Skin Types I and VI. The study will also generate additional safety data to address FDA 510(k) feedback regarding represe...
What is the current status of trial NCT07473661?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2026-02-27. Estimated completion is 2026-04.
What conditions does trial NCT07473661 study?
This clinical trial studies the following conditions: Healthy Adult.
What interventions are being tested in trial NCT07473661?
The interventions under investigation include: SILURCLOUD Fibrous Collagen Matrix (DEVICE), 0.5% Sodium Lauryl Sulfate in Distilled Water (DRUG), Glycerosaline (DRUG).
Who is sponsoring clinical trial NCT07473661?
This trial is sponsored by SerenaGroup, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07473661 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Adult
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Avocado and Postprandial Responses
RECRUITING · NA
-
Skin Prick Test to Evaluate Immunogenic Response of SILURCLOUD™ Fibrous Collagen Matrix in Healthy Volunteers
RECRUITING · NA
-
Study to Investigate Vagus Nerve Stimulation to Augment Executive Function in Healthy and Cognitively Impaired Populations
RECRUITING · NA
-
Nicotinamide Adenine Dinucleotide Responses to a Nutritional Supplement
RECRUITING · NA
-
The Effects of Finger Extensor Training on Climbing Performance Compared With Traditional Flexor Training
ACTIVE NOT RECRUITING · NA
-
The Effect of Virtual Reality on Pain and Memory.
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.